WEED, Inc. (BUDZ) Financial Statements (2023 and Earlier)
Company Profile
Business Address |
4920 N. POST TRAIL TUCSON, AZ 85750 |
State of Incorp. | NV |
Fiscal Year End | December 31 |
Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 20 | 2 | 39 | 44 | 13 | 166 | 8 | ||
Cash and cash equivalents | 20 | 2 | 39 | 44 | 13 | 166 | 8 | ||
Receivables | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
Prepaid expense | 21 | 34 | 23 | 26 | 30 | 33 | 23 | ||
Deposits current assets | 302 | 222 | 50 | 212 | 182 | 142 | |||
Other undisclosed current assets | 50 | 252 | |||||||
Total current assets: | 42 | 338 | 334 | 373 | 255 | 383 | 174 | ||
Noncurrent Assets | |||||||||
Property, plant and equipment | 1,877 | 1,432 | 1,465 | 1,492 | 1,521 | 1,559 | 1,705 | ||
Intangible assets, net (including goodwill) | 41 | 41 | 42 | 42 | 43 | 44 | 45 | ||
Intangible assets, net (excluding goodwill) | 41 | 41 | 42 | 42 | 43 | 44 | 45 | ||
Total noncurrent assets: | 1,917 | 1,473 | 1,507 | 1,534 | 1,564 | 1,603 | 1,750 | ||
TOTAL ASSETS: | 1,959 | 1,811 | 1,841 | 1,907 | 1,819 | 1,986 | 1,924 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 679 | 638 | 616 | 592 | 545 | 545 | 500 | ||
Accounts payable | 246 | 251 | 254 | 238 | 242 | 264 | 263 | ||
Accrued liabilities | 17 | 14 | 11 | 22 | 272 | 16 | 13 | ||
Employee-related liabilities | 366 | 330 | 312 | 302 | 239 | 202 | |||
Interest and dividends payable | 51 | 44 | 39 | 30 | 30 | 27 | 23 | ||
Debt | 66 | 68 | 76 | 92 | 115 | 149 | 148 | ||
Due to related parties | 1 | 1 | 1 | 1 | 1 | 1 | |||
Other liabilities | 19 | ||||||||
Other undisclosed current liabilities | 596 | 304 | 297 | 287 | 259 | 287 | 284 | ||
Total current liabilities: | 1,342 | 1,011 | 989 | 972 | 937 | 983 | 932 | ||
Noncurrent Liabilities | |||||||||
Total liabilities: | 1,342 | 1,011 | 989 | 972 | 937 | 983 | 932 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent, including: | 618 | 801 | 851 | 935 | 882 | 1,003 | 992 | ||
Common stock | 119 | 118 | 118 | 115 | 113 | 113 | 112 | ||
Common stock, share subscribed but unissued, subscriptions receivable | (40) | 466 | 356 | 425 | (396) | ||||
Additional paid in capital | 82,976 | 82,682 | 82,579 | 81,318 | 80,403 | 80,247 | 80,089 | ||
Accumulated other comprehensive loss | (2) | (2) | (1) | (1) | (0) | (1) | (1) | ||
Accumulated deficit | (82,833) | (82,364) | (82,191) | (80,963) | (79,991) | (79,781) | (79,605) | ||
Other undisclosed stockholders' equity attributable to parent | 356 | 366 | 386 | 793 | |||||
Total stockholders' equity: | 618 | 801 | 851 | 935 | 882 | 1,003 | 992 | ||
TOTAL LIABILITIES AND EQUITY: | 1,959 | 1,811 | 1,841 | 1,907 | 1,819 | 1,986 | 1,924 |
Income Statement (P&L) ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
---|---|---|---|---|---|---|---|---|
Operating expenses | (461) | (170) | (1,208) | (956) | (205) | (215) | (556) | |
Operating loss: | (461) | (170) | (1,208) | (956) | (205) | (215) | (556) | |
Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (8) | (3) | (20) | (16) | (5) | 39 | (18) | |
Interest and debt expense | (6) | (3) | (17) | (7) | (10) | (8) | (18) | |
Loss from continuing operations before equity method investments, income taxes: | (475) | (177) | (1,245) | (979) | (219) | (185) | (593) | |
Other undisclosed income from continuing operations before income taxes | 39 | |||||||
Net loss: | (436) | (177) | (1,245) | (979) | (219) | (185) | (593) | |
Other undisclosed net income (loss) attributable to parent | (33) | 3 | 17 | 7 | 10 | 8 | 18 | |
Net loss available to common stockholders, diluted: | (469) | (173) | (1,228) | (972) | (210) | (177) | (575) |
Comprehensive Income ($ in thousands)
12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (436) | (177) | (1,245) | (979) | (219) | (185) | (593) | |
Other comprehensive income (loss) | 3 | (1) | 0 | (1) | 1 | (0) | 0 | |
Comprehensive loss: | (433) | (178) | (1,245) | (979) | (218) | (185) | (592) | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (33) | 3 | 17 | 7 | 10 | 8 | 18 | |
Comprehensive loss, net of tax, attributable to parent: | (466) | (174) | (1,228) | (972) | (208) | (177) | (574) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.